Holy Cross Hospital Inc. — Fort Lauderdale, Florida

Holy Cross Hospital Inc. is a clinical research site located in Fort Lauderdale, Florida, United States 33308.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Holy Cross Hospital Inc. has participated in 12 clinical trials with 1 currently active.

Therapeutic areas: Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, Advanced or Metastatic Breast Cancer.

Sponsors: EMD Serono Research & Development Institute, Inc., Menarini Group, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Holy Cross Hospital Inc.?

Holy Cross Hospital Inc. has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Holy Cross Hospital Inc. conducted?

Holy Cross Hospital Inc. has 12 clinical trials on record, with 1 currently active. Their work covers Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, Advanced or Metastatic Breast Cancer.

Is Holy Cross Hospital Inc. accredited by Crixeo Health?

Yes — Holy Cross Hospital Inc. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Holy Cross Hospital Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.